ElevenLabs

The ElevenLabs pre-IPO CFD on CoinUnited gives retail traders synthetic price exposure to one of the fastest-rerating private AI companies in the current market cycle, without the accreditation requirements, large capital minimums, or brokerage paperwork that traditionally gate private-market participation.

The Access Wedge

Private-market platforms such as EquityZen, Forge Global, and Hiive provide secondary access to pre-IPO names, but typically restrict participation to accredited investors and impose minimums that run into the tens of thousands of dollars.

Accounts are funded and withdrawn in crypto, so no traditional bank account or lengthy onboarding paperwork is involved.

The CFD is a synthetic instrument. It tracks ElevenLabs' private-market reference price and confers no shareholding, voting rights, dividends, or IPO allocation. Traders gain price exposure, nothing more.

The Valuation Trajectory

ElevenLabs' private valuation has re-rated sharply within a compressed timeframe. The Series C in January 2025 set a post-money figure of $3.3 billion. The Series D in February 2026, a $500 million raise, brought that figure to $11 billion, reported by Reuters, Bloomberg, and TechCrunch.

By July 2026, Bloomberg and Reuters reported the company was exploring an employee stock tender that would value it at approximately $22 billion: roughly double the Series D level within months.

Three qualitative drivers support that trajectory:

• -Revenue scale. The company crossed $330 million in annual recurring revenue, placing it among the top-revenue voice AI businesses in the private market.
• -Institutional depth. The investor base spans early venture (Andreessen Horowitz, Sequoia Capital, ICONIQ Growth) through to large asset managers and strategic corporates including BlackRock, Nvidia, Salesforce Ventures, D.E. Shaw, Schroders, and Santander, reported by TechCrunch. That breadth signals demand from capital allocators beyond the typical VC cohort.
• -Commercial expansion. Voice AI adoption is accelerating across media, enterprise software, accessibility tooling, and developer infrastructure, widening ElevenLabs' addressable market and supporting premium private-market pricing.

For context on how private-market dynamics are shaping pre-IPO instruments more broadly in this cycle, see the 2026 Pre-IPO Market Outlook.

Risk Factors

Traders should weigh the following risks carefully before establishing a position.

The distinction between the Series D valuation and the secondary-market indication matters practically: a tender offer reflects a specific transaction structure at a point in time, not continuous market pricing. Traders should not treat either figure as a floor or ceiling for the CFD's reference price going forward.

The ELEVENLABS_IO instrument on CoinUnited.io is a pre-IPO CFD that provides synthetic price exposure to ElevenLabs' private-market reference price. It is not equity: holding this instrument confers no shareholding, no voting rights, no dividends, and no allocation in any future IPO.

The reference price is derived from private-market valuation indications, such as reported funding rounds and secondary transaction data, rather than from an exchange-listed share price.

Instrument Mechanics

Traders should understand several structural characteristics before sizing a position:

• -Instrument type: Synthetic pre-IPO CFD. Price exposure only, not ownership of any ElevenLabs shares or securities.
• -Reference price: Tracks private-market valuation indications. As of August 2026, publicly reported figures range from an $11 billion Series D post-money valuation (February 2026) to an indicative ~$22 billion figure associated with a planned employee tender offer (July 2026).
• -Leverage: Up to 100x is available on the ELEVENLABS_IO CFD.
• -Minimum exposure: From US$100 per position.
• -Accreditation: None required.

• -Account funding: Crypto deposits and withdrawals only, no traditional bank account or conventional brokerage paperwork required.

Leverage and Position Sizing

Up to 100x leverage is available, but the nature of private-market price discovery warrants careful sizing. Unlike liquid public equities, pre-IPO reference prices can re-rate sharply on discrete events rather than through continuous market trading.

The ElevenLabs valuation record illustrates this directly: the indicative valuation roughly doubled, from $11 billion to approximately $22 billion, within a matter of months, driven by a single reported secondary transaction. Such moves, compressed into brief windows, amplify both upside and liquidation risk at high leverage multiples.

A worked example using hypothetical figures:

The table illustrates that at maximum leverage, a 1% adverse move in the reference price would exhaust the margin on that position. Given valuation re-ratings of 50–100% have occurred across ElevenLabs' recent funding history, using a fraction of available leverage provides meaningful buffer against gap moves.

IPO Event Handling

Traders holding the ELEVENLABS_IO CFD at the time of an actual IPO event should review CoinUnited's specific product terms governing that scenario. Common mechanics for pre-IPO synthetic instruments include reference-price conversion to a public-market price, position settlement at a defined closing price, or position closure.

The applicable terms govern the instrument's lifecycle and determine how any open position is treated at the moment a listing occurs. Reviewing these terms before opening a position, not after an IPO announcement, is advisable.

Practical Entry and Exit Considerations

Pre-IPO synthetics typically carry wider spreads than liquid public-market instruments, reflecting the lower frequency of private-market price discovery and the absence of a continuous order book. Traders should account for spread costs when calculating realistic P&L on short-duration trades.

The primary drivers of reference price moves for ELEVENLABS_IO are discrete news events rather than intraday market flows. Key catalysts to monitor include:

• -IPO filing announcements or S-1 submissions: Signal a shift from private to public valuation framework.
• -New funding rounds or secondary transactions: Directly reset the reference valuation level.
• -ARR or revenue disclosures: Material updates to growth metrics that inform private-market pricing.
• -Tender offer confirmations: Structured secondary sales, such as the ~$22 billion employee stock sale reported in July 2026, establish hard reference points.

These events represent the windows of highest informational activity for the instrument. For broader context on private-market dynamics affecting pre-IPO instruments, see the 2026 Pre-IPO Market Outlook.